The therapeutic effect of liver transplantation in 14 children with homozygous familial hypercholesterolemia: a prospective cohort

2024-9-1

Association between changes in high-density lipoprotein cholesterol and risk of cardiovascular disease

2024-9-1

Rapid Lipid-Lowering Response in Two Cases of Autosomal Recessive Hypercholesterolemia

2024-9-1

Akira Endo (1933-2024), In Memoriam,

2024-9-1

Evaluation of plasma phytosterols in sitosterolemia, their kindreds and hyperlipidemia subjects

2024-9-1

Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association

2024-9-1

Challenges and opportunities for identifying people with Familial Hypercholesterolaemia in the UK: Evidence from the National FH PASS database

2024-9-1

Attitudes and barriers to lipoprotein(a) testing: A survey of providers at the University of Pennsylvania health system

2024-8-1

Fibrinogen and plasma clot properties are associated with apolipoprotein B and apolipoprotein B-containing lipoproteins in Africans

2024-8-1

Safety and Efficacy of Moderate-intensity statin plus ezetimibe versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease: a meta-analysis

2024-8-1

Concordance between LDL-C estimated by various formulas and directly measured LDL-C

2024-8-1

Monocyte/lymphocyte ratio as a risk factor of cardiovascular and all-cause mortality in coronary artery disease with low-density lipoprotein cholesterol levels below 1.4 mmol/L: A large longitudinal multicenter study

2024-8-1

Long Term Association of Low-Density Lipoprotein Subtypes with Coronary Artery Calcium Score and Atherosclerotic Cardiovascular Disease Events: Insights from HeartSCORE Study

2024-8-1

Increased Circulating Levels of Malondialdehyde-modified Low-density Lipoprotein in Patients with Coronary Microvascular Dysfunction

2024-8-1

Genetic variants in triglyceride metabolism genes among individuals with hypertriglyceridemia in Colombia

2024-8-1

Lipid Profile and Risk Factors for Neoatherosclerosis after Drug-eluting Stent Implantation in Acute Coronary Syndrome

2024-8-1

Early health technology assessment of gene silencing therapies for lowering lipoprotein(a) in the secondary prevention of coronary heart disease

2024-8-1

The clinical and demographic characteristics of patients with late-diagnosed cerebrotendinous xanthomatosis in a Turkish population

2024-8-1

†Patients Perceive a Considerable Treatment Burden in the First Year after a Myocardial Infarction: Results from an Online US Patient Survey

2024-7-1

What's Next for Lipoprotein(a)? A National Lipid Association Report from an Expert Panel Discussion

2024-7-1

Study Design of a Phase 3 Randomized Controlled Trial Evaluating the Efficacy and Safety of Pegozafermin in Patients with Severe Hypertriglyceridemia

2024-7-1

†Obicetrapib Treatment Increases Pre-Beta1 HDL and Lipophilic Antioxidants in the Ocean and Rose2 Studies

2024-7-1

†Age- and Sex-Specific Nomographic CT Quantitative Plaque Data From a Large International Cohort

2024-7-1

Utilizing innovative implementation strategies for familial hypercholesterolemia: Implementation outcomes from the IMPACT-FH study

2024-7-1

Serum mature and furin-cleaved proprotein convertase subtilisin/kexin type 9 levels and their association with cardiovascular events in statin-treated patients with cardiovascular disease

2024-7-1

Genetic association analyses highlight apolipoprotein B as a determinant of chronic kidney disease in patients with type 2 diabetes

2024-7-1

The Outcome of Coronary Artery Bypass Graft in Patient with Prediabetes.

2024-7-1

Multidisciplinary Management of Lipoprotein X-Induced Hyperlipidemia Secondary to Drug-Induced Liver Injury

2024-7-1

Fellow Quality Improvement Project: Identification of High Risk CAD Patients and Referral to Newly Established Lipid Clinic, What are the Clinical Implications?

2024-7-1

Development of a Clinical Diagnostic Score for Familial Chylomicronemia Syndrome (FCS)

2024-7-1

Accelerated Atherosclerosis in a Patient With Multifactorial Chylomicronemia Syndrome (MCS), Elevated Lp(a), APOE2/4 Genotype and Diabetes Mellitus.

2024-7-1

†Utility of AI-QCPA: Results of the Decisions for Treating Coronary Disease are Changed in Patients Evaluated with Quantified Plaque Analysis

2024-7-1

Association Between Niacin-ER Use, Safety, and Cardiovascular Events. A Single Center Experience.

2024-7-1

Differences in Clinical Outcomes Between Non-Obese Caucasians and African American Populations with Hyperlipidemia

2024-7-1

*Real-World Experience with Inclisiran at a Large Academic Lipid Clinic

2024-7-1

Unmasking the Silent Culprit: Lipoprotein(a) Elevation in a Previously Healthy Individual

2024-7-1

FADS2 Indel Polymorphism rs66698963 Predicts Colorectal Polyp Prevention by the n-3 Fatty Acid EPA

2024-7-1

Lomitapide in Pediatric Patients with Homozygous Familial Hypercholesterolemia – Analysis of Secondary and Safety Endpoints from the APH-19 Study

2024-7-1

Pancreatitis Polygenic Risk Score is Associated with Acute Pancreatitis in Multifactorial Chylomicronemia Syndrome

2024-7-1

A Novel Nanoparticle Lipoprotein Free Cholesterol Mass Transfer Assay

2024-7-1

†Role of DNA methylation on 15-Lipoxygenase-1 gene expression in Osteoarthritis

2024-7-1

Lipoprotein(a)’s Prediction of Cardiovascular Disease Events When Accessed via Electronic Health Records

2024-7-1

Clinical Outcomes in Patients Admitted with Acute Coronary Syndrome Affected by Protein Calorie Malnutrition.

2024-7-1

+Racial Inequities in Coronary Artery Calcium Screening and Follow-up

2024-7-1

Clinical Outcomes And Mortality in Heart Failure And Chronic Kidney Disease Patients Admitted With Non-Variceal Upper Gastrointestinal Bleeding

2024-7-1

Development of the Family Heart Foundation™ Flag, Identify, Network, Deliver—Familial Hypercholesterolemia (FIND-FH™) Implementation Toolkit

2024-7-1

†Assessment of Unmet Clinical Needs and Healthcare Resource Use among Statin-Treated Patients with or at Risk of Developing ASCVD

2024-7-1

Oleocanthal-Rich Olive Oil's Effect on Postprandial Platelet Activity and Oxidative Stress Markers of Type 2 Diabetic Patients

2024-7-1

Elevated Levels of Lp(a) are Associated with Circulating Levels of PCSK9 and Coronary Atherosclerosis as Detected by Cardiac Computed Tomography Angiography

2024-7-1

†High Rates of Cardiovascular Events in Patients with Multivessel Disease in the First Year Post-Myocardial Infarction: A Systematic Literature Review

2024-7-1